Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 5 | Issue 2 | 2014 | pp. 163–165Open access
A case of tinnitus induced by chlorpromazine in a pediatric patient
- 2,
- 2,
- 3,
- 3,
- 2,
- 2,
- ,
- 2,
- 2*
- 1 Department of Biomedical and Clinical Sciences, Luigi Sacco University Hospital.
- 2 Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Milan.
- 3 Scientific Institute for Research, Hospitalization and Health Care Eugenio Medea, Bosisio Parini, Lecco, Italy Case Report.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sonia Radice
Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Milan.
Email: sonia.radice@unimi.it
Copyright: © 2014 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2014
- Received:
- May 2, 2013
- Accepted:
- Nov 1, 2013
How to cite
Carnovale, C., Pellegrino, P., Beretta, S., Zuccotti, G. V., Perrone, V., Antoniazzi, S., Pozzi, M., Clementi, E., & Radice, S. (2014). A case of tinnitus induced by chlorpromazine in a pediatric patient. Journal of Pharmacology and Pharmacotherapeutics, 5(2), 163–165. https://doi.org/10.4103/0976-500X.130110
Abstract
Chlorpromazine is a well‑known antipsychotic agent that binds with a variety of receptors in the central nervous system. To date, chlorpromazine has never been associated with onset of hearing disorders and tinnitus. We report on an unexpected suspect adverse reaction to chlorpromazine that occurred in a 12‑year‑old boy, affected by severe generalized anxiety disorder. After treatment with chlorpromazine, the patient experienced an enhanced sensitivity to sounds accompanied by perception of noises of the buzzing or ringing type. This clinical case is of great clinical interest as chlorpromazine is not currently included among potentially ototoxic drugs.
Keywords
Subject
Article metadata
| Title | A case of tinnitus induced by chlorpromazine in a pediatric patient |
|---|---|
| Authors | Carla Carnovale; Paolo Pellegrino; Silvia Beretta; Gian Vincenzo Zuccotti; Valentina Perrone; Stefania Antoniazzi; Marco Pozzi; Emilio Clementi; Sonia Radice |
| Affiliations | Department of Biomedical and Clinical Sciences, Luigi Sacco University Hospital.; Department of Pediatrics, Luigi Sacco Hospital, University of Milan, Milan.; Scientific Institute for Research, Hospitalization and Health Care Eugenio Medea, Bosisio Parini, Lecco, Italy Case Report. |
| Corresponding author | sonia.radice@unimi.it |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 5, Issue 2 (2014) |
Also in this issue
- Why patients in pain cannot get “God’s own medicine?”pp. 81–2
- Switch over from intravenous to oral therapy: A concise overviewpp. 83–87
- Off‑label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authoritiespp. 88–92
- Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trialpp. 93–94
- Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reportspp. 100–138
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026